Back to search
FDAFDA · Food and drugs·Recall number D-169-2013

Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDC 0409-6102-04

Published March 6, 2013 · Recall initiated: January 10, 2013

Summary

FDA records drug Class II recall D-169-2013, published March 6, 2013 and initiated January 10, 2013. Recalling firm: Hospira, Inc.; Status: Terminated; Reported quantity: 63,900 vials; Lot: 18-099-DK. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial

What to do

Voluntary: Firm initiated · Letter

Get an email if FUROSEMIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
FUROSEMIDE
Manufacturer
Hospira, Inc.
Distributor
Nationwide
Lot
18-099-DK
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Furosemide Injection USP (10 mg/mL), 4 mL in 5 mL Fliptop Vial, Rx only, Hospira Inc., Lake Forest, IL --- NDC 0409-6102-04 recalled?

Yes. FDA published recall D-169-2013 on March 6, 2013. Reported hazard: Lack of Assurance of Sterility; possible loose crimp applied to fliptop vial

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: FUROSEMIDE.